BetraLif is beginning Phase 1 of construction for its 11,340 sq. ft production site in L'Ange-Gardien. This company will offer a range of medical cannabis products that meet Health Canada's stringent quality and safety standards
“The development of the production site will take place in three distinct phases, explains co-founder and CEO Marc St-Arnaud. "Phase 1, includes building a 11, 340 sq. ft. cleanroom to produce 668 kg of medical cannabis. Phase 2, in January 2021, a 17,000 sq. ft. flowering and extraction room that will quickly be added to phase one with 2,400 kg of cannabis. Phase 3, facilities over 120,000 feet will be built adjacent to Phases 1 and 2, for a total of more than 148,000 sq. ft. BetraLif has been the subject of a comprehensive evaluation and review, including enhanced safety checks to achieve our Good Production Practice standards.”
“Our facilities will be equipped with state-of-the-art environmental controls in order to cultivate a stable and consistent product for the medical/pharmaceutical market,” explains horticulturist Dr. Av Singh, PhD in agronomy. Being compliant to the high standards of the Cannabis Act ensures quality medicine for our patients.’’
“BetraLif's presence within the community generates positive and significant economic spinoff," said Marc Louis-Seize, L’Ange-Gardien municipal Mayor. Phase 1 will create 15 jobs, phase 2, 25 jobs and at the end of all three phases, we are looking at about 100 jobs within the next few years.”
"In the past five years, BetraLif has built one of the industry's most sought-after team to achieve its goals. This will make it one of the most coveted companies for its product quality."